Literature DB >> 6179086

Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.

J A López de Castro, J L Strominger, D M Strong, H T Orr.   

Abstract

The primary structure of two highly crossreactive human histocompatibility antigens, HLA-A28 and HLA-A2, has been determined to 96% and 90%, respectively, of the papain-solubilized molecules. Their sequences have been compared with the sequence of HLA-B7 and with each other in order to outline the sites of diversity. The overall homology between HLA-B7 and these HLA-A antigens is 86%. A large majority of the differences are located between residues 43 and 195. Within this area, substitutions cluster in at least three segments--residues 65-80, 105-116, and 177-194. HLA-A28 and HLA-A2 show 96% homology. Most of the differences fall within segments 65-74 and 107-116. These results strongly support the suggestion that residues in these segments are integral parts of the alloantigenic determinants of HLA-A28 and HLA-A2. It is further proposed that these three clusters may constitute major, albeit not exclusive, sites of antigenic diversity in human histocompatibility antigens. The nature of the differences among HLA-B7, HLA-A28, and HLA-A2 in the first variable segment suggests that gene conversion might play some role in the generation of HLA polymorphism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179086      PMCID: PMC346518          DOI: 10.1073/pnas.79.12.3813

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Detection of peptides by fluorescence methods.

Authors:  C Y Lai
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

Review 2.  Evolutionary significance of the HL-A system.

Authors:  W F Bodmer
Journal:  Nature       Date:  1972-05-19       Impact factor: 49.962

3.  Papain-solubilized HL-A antigens from cultured human lymphocytes contain two peptide fragments.

Authors:  P Cresswell; M J Turner; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

4.  Papain-solubilized HL-A antigens. Chromatographic and electrophoretic studies of the two subunits from different specificities.

Authors:  P Cresswell; R J Robb; M J Turner; J L Strominger
Journal:  J Biol Chem       Date:  1974-05-10       Impact factor: 5.157

5.  Use of fluorescamine in the chromatographic analysis of peptides from proteins.

Authors:  N Nakai; C Y Lai; B L Horecker
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

6.  HL-A substances from human spleens.

Authors:  A R Sanderson
Journal:  Nature       Date:  1968-10-12       Impact factor: 49.962

7.  A certain symmetry: histocompatibility antigens compared with immunocyte receptors.

Authors:  F M Burnet
Journal:  Nature       Date:  1970-04-11       Impact factor: 49.962

8.  Carbohydrate moiety of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation.

Authors:  P Parham; B N Alpert; H T Orr; J L Strominger
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

Review 9.  beta2-Microglobulins.

Authors:  M D Poulik; R A Reisfeld
Journal:  Contemp Top Mol Immunol       Date:  1975

10.  Reversible modification of arginine residues. Application to sequence studies by restriction of tryptic hydrolysis to lysine residues.

Authors:  L Patthy; E L Smith
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

View more
  53 in total

1.  Selection for class II Mhc heterozygosity by parasites in subterranean mole rats.

Authors:  E Nevo; A Beiles
Journal:  Experientia       Date:  1992-05-15

2.  Evolution of the mouse H-2K region: a hot spot of mutation associated with genes transcribed in embryos and/or germ cells.

Authors:  Y I Yeom; K Abe; K Artzt
Journal:  Genetics       Date:  1992-03       Impact factor: 4.562

Review 3.  Concerted and birth-and-death evolution of multigene families.

Authors:  Masatoshi Nei; Alejandro P Rooney
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

4.  Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.

Authors:  M A Vega; A Ezquerra; S Rojo; P Aparicio; R Bragado; J A López de Castro
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells.

Authors:  E P Cowan; M L Jelachich; W E Biddison; J E Coligan
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Identification of human genomic clones coding the major histocompatibility antigens HLA-a2 and HLA-B7 by DNA-mediated gene transfer.

Authors:  J A Barbosa; M E Kamarck; P A Biro; S M Weissman; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  Anti-HLA antibodies of predetermined specificity: a chemically synthesized peptide induces antibodies specific for HLA-A,B heavy chain.

Authors:  W R Church; L E Walker; R A Houghten; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the major histocompatibility complex.

Authors:  L R Pease; D H Schulze; G M Pfaffenbach; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Correction of complex heteroduplexes made of mouse H-2 gene sequences in Escherichia coli K-12.

Authors:  B Cami; P Chambon; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  High-level expression of a cloned HLA heavy chain gene introduced into mouse cells on a bovine papillomavirus vector.

Authors:  D DiMaio; V Corbin; E Sibley; T Maniatis
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.